OCUL logo

OCUL
Ocular Therapeutix Inc

12,074
Mkt Cap
$1.95B
Volume
17.1M
52W High
$16.44
52W Low
$5.79
PE Ratio
-6.21
OCUL Fundamentals
Price
$10.98
Prev Close
$8.94
Open
$8.73
50D MA
$10.48
Beta
1.43
Avg. Volume
5.23M
EPS (Annual)
-$1.42
P/B
2.95
Rev/Employee
$159,849.23
$1,613.02
Loading...
Loading...

About

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
325

Frequently Asked Questions

What is Market Cap of Ocular Therapeutix Inc?
What is the 52-week high for Ocular Therapeutix Inc?
What is the 52-week low for Ocular Therapeutix Inc?
What is Ocular Therapeutix Inc stock price today?
What was Ocular Therapeutix Inc stock price yesterday?
What is the PE ratio of Ocular Therapeutix Inc?
What is the Price-to-Book ratio of Ocular Therapeutix Inc?
What is the 50-day moving average of Ocular Therapeutix Inc?
How many employees does Ocular Therapeutix Inc have?

Latest OCUL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.